Not all Iodine-131 is created equal

Jubilant DraxImage launches “Not all Iodine-131 is created equal” Campaign

Jubilant DraxImage is pleased to announce the launch of its “Not all Iodine-131 is created equal” campaign. We wish to raise awareness about the differences between FDA approved pharmaceutical-grade I-131 drug products such as Jubilant DraxImage’s HICON® I-131 and radiochemical-grade I-131. Our communication is intended for Nuclear Technologists and Nuclear Medicine Physicians involved in Thyroid patients’ care.

JDI supports the ongoing education of the Nuclear Medicine Community through a number of programs. Today, we are creating the first ever “HICON® Continuing Education Grant” initiative bringing to light the extraordinary value that Nuclear Medicine brings to Thyroid patients. To qualify for a chance to win a $5,000 unrestricted grant towards continuing education, nuclear medicine professionals in the U.S.A. are invited to visit this webpage: and complete a very short survey.

This initiative is another example of Jubilant DraxImage’s commitment to quality and education in support of nuclear medicine.

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.